Two compounds anchor most tissue-repair-focused peptide research: BPC-157 and GHK-Cu. They're structurally unrelated and studied through different pathways, but both show up repeatedly in research examining healing, remodeling, and recovery-related mechanisms.

BPC-157

BPC-157 is a synthetic peptide derived from a protein found in gastric juice. Its research profile is unusually broad for a single compound — studies span gastrointestinal healing, tendon and ligament repair models, and general tissue-repair pathway characterization. Much of the research interest stems from its apparent stability and activity across multiple tissue types rather than a single narrow mechanism, which is part of why it's become a common reference compound in comparative studies.

GHK-Cu

GHK-Cu (Glycyl-L-Histidyl-L-Lysine bound to copper) is a naturally occurring copper-binding peptide found in human plasma, with concentration known to decline with age — a large part of why it draws research interest in tissue remodeling and dermal signaling studies. Its role as a copper carrier is central to its studied mechanism, since copper is a cofactor in multiple enzymatic processes involved in collagen and elastin pathway research.

Why these two are often studied together

Researchers examining recovery and remodeling pathways frequently reference both compounds in the same protocols — not because they share a mechanism, but because they represent two distinct angles (systemic peptide signaling vs. localized copper-dependent remodeling) on the same broad research question.

Sourcing

Both compounds are available with third-party purity verification. Given how frequently BPC-157 in particular is referenced across the research literature, lot-to-lot consistency matters — always check that your COA's lot number matches your vial.